Press release
Growth in the Compounding Pharmacy Market Driven by Personalized Medicine Trends
compounding pharmacy market
The compounding pharmacy market is projected to be valued at USD 14.31 billion in 2024 and is anticipated to grow to USD 18.86 billion by 2029, registering a CAGR of 5.68% throughout the forecast period (2024-2029). The market's growth is driven by the increasing demand for personalized medicine, which tailors treatment to the unique characteristics of individual patients.
Report Overview - https://www.mordorintelligence.com/industry-reports/compounding-pharmacy-market
Key Trends Driving the Compounding Pharmacy Market
Rising Demand for Personalized Medicine
The shift towards precision medicine is one of the primary trends fueling the growth of compounding pharmacies. Custom-compounded medications allow healthcare providers to cater to individual patient needs, addressing unique requirements such as dosage forms, allergy-friendly formulations, or specific strength preferences.
Increasing Prevalence of Chronic Diseases
Chronic conditions like diabetes, arthritis, and cardiovascular diseases necessitate tailored therapeutic approaches. Compounding pharmacies are gaining traction for their ability to provide specialized medications that are not commercially available, improving adherence and treatment outcomes.
Advancements in Compounding Technology
Technological advancements, including automated systems and sterile compounding environments, are enhancing the safety, accuracy, and efficiency of compounded medications. These developments are reducing risks associated with contamination and dosing errors, increasing trust in compounded solutions.
Evolving Regulatory Landscape
Regulatory agencies like the FDA are focusing on ensuring safety and quality in compounding practices. Stricter guidelines and oversight mechanisms are driving improvements in production standards and fostering confidence among healthcare providers and patients.
Market Segmentation: Detailed Insights
The Compounding Pharmacy Market is segmented by Product, Therapeutic Area, and End-User:
By Product:
Oral Medications: Tablets, capsules, and suspensions tailored to patient needs.
Topical Medications: Creams, ointments, and gels formulated for skin application.
Suppositories: Specialized formulations for rectal or vaginal use.
Injectables: Custom doses for precise medical requirements.
Others: Including ophthalmic and nasal preparations.
By Therapeutic Area:
Pain Management: Customized solutions for chronic and acute pain relief.
Hormone Replacement Therapy (HRT): Formulations addressing specific hormonal imbalances.
Dermatology: Treatments for skin conditions such as eczema and psoriasis.
Others: Covering a range of conditions, including infectious diseases and oncology.
By End-User:
Hospitals and Clinics: Bulk compounding for patient treatments.
Retail Pharmacies: Individualized prescriptions for walk-in customers.
Home Healthcare: Personalized medications for remote patient care.
This segmentation underscores the market's versatility, catering to diverse medical needs and healthcare settings.
Get a Customized Report Tailored to Your Requirements:- https://www.mordorintelligence.com/market-analysis/alternative-medicine
Key Players: Shaping the Future of Compounding Pharmacy
Leading companies in the Compounding Pharmacy Market are driving innovation, ensuring compliance with regulations, and expanding their offerings to meet growing demand. Key players include:
Fagron NV: A global leader in pharmaceutical compounding with a focus on innovation and quality.
B. Braun Medical Inc.: Known for sterile compounding and injectable solutions.
PharMEDium Services LLC: Specializes in customized sterile preparations for hospitals and clinics.
Advanced Pharma: Provides a wide range of compounded medications with a focus on pain management.
Athenex Inc.: Innovates in oncology compounding and other specialty areas.
These companies are investing heavily in R&D, partnerships, and compliance to maintain a competitive edge.
Conclusion: A Promising Future for Compounding Pharmacy
The Compounding Pharmacy Market is set to experience robust growth, driven by increasing demand for personalized medicine and advanced therapeutic solutions. Innovations in compounding technology, along with stringent regulatory frameworks, are shaping a more efficient and reliable market landscape. As chronic diseases and patient-specific needs rise, compounded medications will play a critical role in improving healthcare outcomes globally.
Industry Related Reports
Pharmaceutical Isolator Market: The report provides a comprehensive analysis and valuation of the Global Pharmaceutical Isolators Market. The market is segmented based on Type (Closed Isolator Systems and Open Isolator Systems), Application (Aseptic Isolators, Containment Isolators, and Other Applications), End-user (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Other End-users), and Geography, which includes regions such as North America, Europe, Asia-Pacific, the Middle East, Africa, and South America.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/pharmaceutical-isolator-market
polybutylene terephthalate pbt market: The Polybutylene Terephthalate (PBT) Market is categorized by End-User Industry (Automotive, Electrical and Electronics, Industrial and Machinery) and by Region (Africa, Asia-Pacific, Europe, Middle East, North America, and South America). The market is analyzed in terms of both Value (USD) and Volume (tons). Key data points include automobile production volumes, new construction floor area, plastic packaging production volumes, plastic resin production, imports and exports, and plastic resin prices.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/polybutylene-terephthalate-pbt-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth in the Compounding Pharmacy Market Driven by Personalized Medicine Trends here
News-ID: 3786520 • Views: …
More Releases from Mordor Intelligence
Impregnating Resins Market Analysis by Top Key Players Von Roll Holding AG, Axal …
A recently released report by Mordor Intelligence analyzes the "Impregnating Resins Market," highlighting key developments, market growth, and expected trends through 2030.
Impregnating Resins Market
The global Impregnating Resins Market is showing steady growth, with projections indicating a rise from USD 1.75 billion in 2025 to USD 2.24 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.08%. These resins play a critical role in enhancing the insulation and mechanical…
Business Jet Market Size to Reach USD 30.91 billion by 2030, Driven by Rise in P …
Introduction
The Business Jet Market size is estimated at 25.69 billion USD in 2025, and is expected to reach 30.91 billion USD by 2030, growing at a CAGR of 3.77% during the forecast period (2025-2030). This growth reflects the rising preference for point-to-point connectivity, corporate travel efficiency, and increased adoption of private aviation by high-net-worth individuals and enterprises.
As corporations focus on flexible mobility and time savings, business jets continue to…
Bovine Mastitis Market to Reach USD 2.16 billion by 2030 Amid Rising Focus on An …
Mordor Intelligence has published a new report on bovine mastitis market offering a comprehensive analysis of trends, growth drivers, and future projection-Mordor intelligence
Introduction
The bovine mastitis market size stands at USD 1.68 billion in 2025 and is projected to reach USD 2.16 billion by 2030, advancing at a 5.15% CAGR. This expansion is driven by the increasing incidence of mastitis among dairy cattle, rising awareness of animal health, and…
Autoimmune Disease Diagnostics Market to Reach USD 8.91 billion by 2030, Driven …
Mordor Intelligence has published a new report on autoimmune disease diagnostics market offering a comprehensive analysis of trends, growth drivers, and future projection-Mordor intelligence
Introduction:
The Autoimmune Disease Diagnostics Market size is estimated at USD 6.17 billion in 2025, and is expected to reach USD 8.91 billion by 2030, at a CAGR of 7.59% during the forecast period (2025-2030). This steady rise reflects global efforts to improve early diagnosis…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
